Version 1: Horizantal scroll

Executive Committee Member - Steven Bukvic - Chairman, Exec. Committee, ACROSS

Steven Bukvic

Chairman, Executive Committee, ACROSS Global
Executive Committee Member - Dr. Jawad Gill - CEO, ORCI Trials

Dr. Jawad Gill

CEO, ORCI Trials
Executive Committee Member - Dr. Ajaykumar B Malle - CEO, CLINICA Research Solutions LLP

Dr. Ajaykumar B Malle

CEO, CLINICA Research Solutions LLP
Executive Committee Member - Denise McNerney - Partner, GLSA

Denise McNerney

Partner, GLSA
Executive Committee Member - Galina Malakhova - CEO, Synergy Research Group

Galina Malakhova

CEO, Synergy Research Group
Executive Committee Member - Spiros Anagnostopoulos - Founder and CEO, Phaze Clinical

Spiros Anagnostopoulos

Founder and CEO, Phaze Clinical
Executive Committee Member - Christophe Tournerie - Founder and CEO, ClinActis

Christophe Tournerie

Founder and CEO, ClinActis
Executive Committee Member - Charles Oviawe - Managing Partner, Guosa Life Sciences

Charles Oviawe

Managing Partner, Guosa Life Sciences
Executive Committee Member - Georges Labaki - CEO, Phoenix Clinical Research, Co-Founder - Balsam

Georges Labaki

CEO, Phoenix Clinical Research, Co-Founder - Balsam
Executive Committee Member - Hiroaki Suzuki - Director, Micron, Inc.

Hiroaki Suzuki

Director, Micron, Inc.
Executive Committee Member - Kálmán Törőcsik - COO, Research Professionals

Kálmán Törőcsik

COO, Research Professionals
Executive Committee Member - Limor Rozner - Business Development Manager, Pharma Clinical

Limor Rozner

Business Development Manager, Pharma Clinical
Executive Committee Member - Mariano Monteagudo - Business Development Director, ACTIVA

Mariano Monteagudo

Business Development Director, ACTIVA
Executive Committee Member - Oleksii Mikheiev M.D., Ph.D. - CEO - Verum.de

Oleksii Mikheiev M.D., Ph.D.

CEO, Verum.de
Executive Committee Member - Zoran Acimovic - CEO - 2GL Outsourcing

Zoran Acimovic

CEO, 2GL Outsourcing
Nikola CIhoric - Founder - Wemedoo oomnia

Nikola Cihoric

Founder, Wemedoo AG

Version 2: Carousel

Accelerate
Your Clinical Trials

Unlock the power of global reach with tailored solutions designed to streamline your clinical trials, reduce costs, and deliver results faster

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Dr. Ajaykumar B Malle

Dr. Ajaykumar B Malle, the Chief Executive Officer of CLINICA Research Solutions LLP, a highly regarded Clinical Research Organization based in Navi Mumbai, India that is dedicated to expediting the development of groundbreaking healthcare solutions. Boasting an impressive career spanning over 22 years in the pharmaceutical, biotechnology, and clinical research industries, Dr. Malle has consistently demonstrated his ability to drive growth, operational excellence, and strategic vision.

Under Dr. Malle’s guidance, CLINICA has solidified its reputation as a trusted partner for both Indian and global pharmaceutical companies, offering top-notch clinical trial management, regulatory consulting, and data analytics services. Driven by his commitment to innovation and customer-centricity, he is known for his exceptional talent in building strong, collaborative teams and fostering a culture of ingenuity.

Dr. Malle’s visionary perspective is centered around making clinical trials more efficient, patient-centered, and accessible, thus accelerating the availability of life-saving treatments. With his extensive expertise in clinical operations, data management, medical writing, regulatory strategy, medical monitoring and business development, he has played a pivotal role in successfully guiding numerous clinical programs from their early-phase development to achieving regulatory approval. Throughout his career, Dr. Malle has earned recognition for his profound understanding of the intricacies of clinical research, as well as his unwavering commitment to upholding the highest standards of scientific and ethical integrity.

Among his notable accomplishments, Dr. Malle holds an Bachelor of Medicine and Bachelor of Surgery (MBBS) degree, along with certifications in PMP®, Diploma in Marketing Management (DMkM), Professional Diploma in Clinical Research (PDCR), and Advanced Certificate Course in Clinical Project Management (ACCPM). He is a sought-after speaker at industry conferences, where he shares his insights on diverse topics related to clinical research innovation, regulatory strategy, and patient engagement. Prior to joining CLINICA Research Solutions LLP, Dr. Malle held influential leadership positions in multinational and domestic pharmaceutical companies, where he spearheaded global clinical operations, strategic development, and regulatory submissions for numerous prominent clinical trials.

Dr. Malle firmly believes that the trajectory of healthcare hinges on unwavering dedication to innovation and a sincere commitment to patients. His leadership philosophy is rooted in transparency, collaboration, and an unwavering passion to make a substantial impact on the lives of patients worldwide.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Galina Malakhova

Galina holds a Bachelor’s degree in Economics and has over 20 years of extensive experience in various executive positions. She has given last 15 years of dedicated work to Synergy. Having risen together with Synergy from company beginnings to a full service CRO with its own philosophy and vast experience, Galina played an important role in building processes, managing long-term partnerships with Synergy clients and partners.

Synergy is now a leading full service contract research organization (CRO) covering many countries. Synergy strives to build a synergetic relationship with every client using time-tested traditional solutions along with up to date risk-based, innovative, technological approaches for the conduct of clinical trials.

Spiros Anagnostopoulos

With more than 20 years of experience in clinical trials field Spiros Anagnostopoulos is the Founder and Managing Director of CRO Phaze Clinical Research & Pharma Consulting S.A. established on 2010 in Athens, Greece.

Biologist by profession, he has a broad experience of all aspects in CRO market starting as a Clinical Research Associate and gaining knowledge and experience from various positions within CROs industry.

Spiros also holds the positions of founding member of Hellenic Association of CROs and Vice President of its Board of Directors for the current term.

Christophe Tournerie

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Hiroaki Suzuki

Hiroaki Suzuki has more than 20 years of experience in clinical research. He started his career by joining a global medical device company in 1996. While working as a system engineer, Mr. Suzuki was involved in bringing several medical devices to the market. In 2000, he moved on to the clinical research field. As a project leader, he successfully led Urology, CNS, and Oncology studies. In 2005, as one of the founding members, Hiroaki Suzuki, helped launch Micron, the first Imaging Contract Research Organization in the Asia-Pacific region. At first, he was appointed a director, a clinical development manager, and a project manager of monitoring services. In 2008, he was involved in the establishment of Micron’s imaging service department as a manager.

Hiroaki Suzuki believes that medical imaging is one of the essential tools to further medical advancement. By setting imaging endpoints, pharmaceutical responses can be evaluated quantitatively, which shortens clinical trials and improves efficiency. Mr. Suzuki has been proactively working to adapt medical imaging technology to clinical trials.

Due to his efforts, Micron has grown to have the largest team of imaging experts in APAC and can support multiple sponsors globally.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Limor Rozner

Limor Rozner is the Business Development Manager and a Project Manager at Pharma Clinical S.A.G (2003) Ltd.

Limor joined Pharma Clinical in 2013 with prior experience in Global pharmaceutical and CRO companies. She has 11 years of extensive experience in clinical trials management, leading multi-national phase II and III trials.In addition to her role as a Business Development Manager and Project Manager, she acts as the country Risk Based Monitoring

Limor holds a Bachelor of Science degree of Biotechnology from Ben-Gurion University of the Negev, Israel.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Oleksii Mikheiev M.D., Ph.D.

Dr. Oleksii Mikheiev is currently the Chief Executive Officer of verum.de GmbH and, former Verum Regional Managing Director at Cluster Verum Office in CIS Countries (1999-2017). From 2016 till 2018, he headed Clinical Trial Subcommittee of European Business Association (the biggest business community NGO in Ukraine). He joined Verum in 1998 after three years of experience as sub-investigator in phase II-III clinical trials. Totally he has 24 years of experience in clinical trials conduction, and, particularly, 20 years of experience in CRO general management. During last ten years Oleksii Mikheiev has been focused on business development, including creation and development of regional offices network. He manages the CRO with strong and sufficient experience of phase II-IV clinical trials set-up, conduction and follow-up, including several FDA inspections with positive outcomes. He was a member of working groups of Ministry of Health (Ukraine) for drafting the clinical trials legislation in Ukraine. He has experience of collaboration with international organizations (WHO, UNAIDS and UNICEF) as the temporary advisor.

Oleksiy Mykheev holds M.D. degree from the National Medical University in Kiev, Ukraine since 1994, received Ph.D. degree in medicine in 2000 and became associate professor in 2014.

Zoran Acimovic

Owner and CEO 2 GL Outsourcing and CRA Academy- Belgrade, Serbia. Zoran Aćimović holds an IT Master of Science. He has more than 25 years of experience in the IT industry and 15 years of experience in the field of health care and clinical trials. In 2011 Zoran co-founded the CRA Academy, which is the only institution in Serbia which educates professional personal working in clinical research and the pharmaceutical industry.

He has been an organizer of informal training for more than 15 years. As the CEO of 2 GL Outsourcing he can provided various services ranging from clinical trials to regulatory affairs, site and project management, quality assurance, HR management and IT management. He started new services in the ex-Yugoslavia (ex-Yu) region as Mobile Research Nurse and Clinical Site Coordinator. For ten years, he successfully organized conferences for clinical trials in Serbia and the Ex-Yu region.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.

Steven Bukvic

Steven Bukvic graduated from Coventry University in 1982 with a degree in Applied Biology. After serving in the commercial sector of the UK motor industry for 8 years, Steven joined the Pharmaceutical Industry in 1990. For the next 27 years Steven’s career in the Pharmaceutical / CRO sectors has covered a broad range of disciplines within the field of clinical research, including clinical site monitoring, project management, pharmacovigilance, training, quality assurance and business operations. Steven has worked in Covance, GSK, MSD and Pfizer to name just a few of the multi-national companies in his career. Steven was instrumental in establishing a CRO in Asia as well as successfully building a number of CRO partnerships. He has also had extensive geographical exposure having worked in the UK, US, Germany, China and the Russian Federation.

Dr. Jawad Gill

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Dr Gill brings over 27 years of experience at leading Pharma companies and CROs across Pakistan, APAC, AME, and CIS. He is a medical graduate, and his expertise covers several facets of clinical research including Clinical Operations, Quality Assurance & Compliance, Medical Monitoring, and Training. Over his career, he has successfully led global teams in various functions.

Eventually he moved on to GSK Singapore as Clinical Research, Quality and Training Manager, where he managed teams across Asia-Pacific, Middle East, Africa, and Central Asian regions. During this time, he developed, trained, and led Clinical Operations country teams in Singapore, Malaysia, and Vietnam.

In his most recent role at Fortrea (previously known as Covance) Singapore, as Head of Clinical QA&C he managed Southeast Asia, Japan, South Korea, Australia, and New Zealand, leading a team of auditors conducting Investigator Site Audits, Process Audits, Vendor Qualification Audits, and supporting Client Audits and Regulatory Inspections.

Dr Gill has held leadership positions in various functions, organizations, and regions and has developed, trained, and led several teams simultaneously. Overall, he has been actively involved in more than 150 clinical studies with different phases, designs, and complexities. He has conducted trainings for clinical research professionals and investigators in Pakistan, China, Taiwan, Philippines, S. Korea, S. Africa, Thailand, Vietnam, Turkey and several other countries. He has been involved in the formulation of clinical research guidelines and regulations in some developing countries.

Dr. Ajaykumar B Malle

Dr. Ajaykumar B Malle, the Chief Executive Officer of CLINICA Research Solutions LLP, a highly regarded Clinical Research Organization based in Navi Mumbai, India that is dedicated to expediting the development of groundbreaking healthcare solutions. Boasting an impressive career spanning over 22 years in the pharmaceutical, biotechnology, and clinical research industries, Dr. Malle has consistently demonstrated his ability to drive growth, operational excellence, and strategic vision.

Under Dr. Malle’s guidance, CLINICA has solidified its reputation as a trusted partner for both Indian and global pharmaceutical companies, offering top-notch clinical trial management, regulatory consulting, and data analytics services. Driven by his commitment to innovation and customer-centricity, he is known for his exceptional talent in building strong, collaborative teams and fostering a culture of ingenuity.

Dr. Malle’s visionary perspective is centered around making clinical trials more efficient, patient-centered, and accessible, thus accelerating the availability of life-saving treatments. With his extensive expertise in clinical operations, data management, medical writing, regulatory strategy, medical monitoring and business development, he has played a pivotal role in successfully guiding numerous clinical programs from their early-phase development to achieving regulatory approval. Throughout his career, Dr. Malle has earned recognition for his profound understanding of the intricacies of clinical research, as well as his unwavering commitment to upholding the highest standards of scientific and ethical integrity.

Among his notable accomplishments, Dr. Malle holds an Bachelor of Medicine and Bachelor of Surgery (MBBS) degree, along with certifications in PMP®, Diploma in Marketing Management (DMkM), Professional Diploma in Clinical Research (PDCR), and Advanced Certificate Course in Clinical Project Management (ACCPM). He is a sought-after speaker at industry conferences, where he shares his insights on diverse topics related to clinical research innovation, regulatory strategy, and patient engagement. Prior to joining CLINICA Research Solutions LLP, Dr. Malle held influential leadership positions in multinational and domestic pharmaceutical companies, where he spearheaded global clinical operations, strategic development, and regulatory submissions for numerous prominent clinical trials.

Dr. Malle firmly believes that the trajectory of healthcare hinges on unwavering dedication to innovation and a sincere commitment to patients. His leadership philosophy is rooted in transparency, collaboration, and an unwavering passion to make a substantial impact on the lives of patients worldwide.

Denise McNerney

With over 25 years of expertise in Business, Marketing, and Technology within the life sciences industry, Denise is a seasoned professional. Her entrepreneurial drive, coupled with vast knowledge and resources, has fueled the creation of multiple successful businesses, streamlined processes, and fostered cohesive teams. Throughout her career, Denise has been instrumental in the launch of innovative products and services, effectively reaching targeted audiences. Building on a foundation of trust, she has cultivated enduring business relationships.

As a Partner at Global Life Sciences Alliance, Denise channels her skills into business development, strategy, and operations. Beyond her professional endeavors, Denise finds joy in volunteering for nonprofits, mentoring individuals and advising startup companies. An avid traveler and enthusiast of an active lifestyle, she embraces diverse experiences in both her personal and professional spheres.

Galina Malakhova

Galina holds a Bachelor’s degree in Economics and has over 20 years of extensive experience in various executive positions. She has given last 15 years of dedicated work to Synergy. Having risen together with Synergy from company beginnings to a full service CRO with its own philosophy and vast experience, Galina played an important role in building processes, managing long-term partnerships with Synergy clients and partners.

Synergy is now a leading full service contract research organization (CRO) covering many countries. Synergy strives to build a synergetic relationship with every client using time-tested traditional solutions along with up to date risk-based, innovative, technological approaches for the conduct of clinical trials.

Spiros Anagnostopoulos

With more than 20 years of experience in clinical trials field Spiros Anagnostopoulos is the Founder and Managing Director of CRO Phaze Clinical Research & Pharma Consulting S.A. established on 2010 in Athens, Greece.

Biologist by profession, he has a broad experience of all aspects in CRO market starting as a Clinical Research Associate and gaining knowledge and experience from various positions within CROs industry.

Spiros also holds the positions of founding member of Hellenic Association of CROs and Vice President of its Board of Directors for the current term.

Christophe Tournerie

Dr Tournerie has more than 20 years’ experience in clinical research in Europe and Asia Pacific including Japan, working with biotechnology companies, pharmaceutical companies and clinical research organizations. After completion of his medical studies in Paris and various hospital assignments in France, Dr Tournerie spent a period of 3 years at the National Medical Research Institute in France in the field of drug development in anti-HIV products. His introduction to the pharmaceutical industry was as Medical Director in an American biotechnology company developing anti-HIV products. Then, he moved to a global CRO, heading the Project management Department for South Europe, and then as Head of Operations in the Japan affiliate. Later, Dr Tournerie headed the Asian clinical research activity for a multi-national Pharmaceutical Company, based in Singapore.

Subsequently, Dr. Tournerie was Vice President Asia Pacific for a global CRO, based in Singapore. During this assignment, Dr Tournerie developed the business strategy for the region, successfully established and directed operations in 12 countries and built a highly professional team.

In 2009, Dr Tournerie founded ClinActis Pte Ltd, a full service CRO headquartered in Singapore and specialized in conducting clinical research in Asia Pacific, offering state of the art quality services, with cost effective solutions.

Dr Tournerie has acquired a vast and diverse experience in all key therapeutic areas as well as clinical trial phases (I to IV), with both large global and smaller scale studies in various geographical areas.

Charles Oviawe

Charles is a Quality Assurance professional with over 20 year’s experience in Quality Systems Development and Management with emphasis on the United States Food and Drug Administration, ICH and global requirements for Good Clinical Practices, Good Laboratory Practice for Nonclinical Laboratory Studies, Good Pharmacovigilance Practices, Clinical Laboratory Improvement Amendments, current Good Manufacturing Practices and Computer System Validation.

Georges Labaki

Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.

Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.

He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.

Hiroaki Suzuki

Hiroaki Suzuki has more than 20 years of experience in clinical research. He started his career by joining a global medical device company in 1996. While working as a system engineer, Mr. Suzuki was involved in bringing several medical devices to the market. In 2000, he moved on to the clinical research field. As a project leader, he successfully led Urology, CNS, and Oncology studies. In 2005, as one of the founding members, Hiroaki Suzuki, helped launch Micron, the first Imaging Contract Research Organization in the Asia-Pacific region. At first, he was appointed a director, a clinical development manager, and a project manager of monitoring services. In 2008, he was involved in the establishment of Micron’s imaging service department as a manager.

Hiroaki Suzuki believes that medical imaging is one of the essential tools to further medical advancement. By setting imaging endpoints, pharmaceutical responses can be evaluated quantitatively, which shortens clinical trials and improves efficiency. Mr. Suzuki has been proactively working to adapt medical imaging technology to clinical trials.

Due to his efforts, Micron has grown to have the largest team of imaging experts in APAC and can support multiple sponsors globally.

Kálmán Törőcsik

Kálmán Törőcsik graduated from University of Szeged in 2005 as doctor of medicine. Since his graduation Kálmán serves the Pharmaceutical Industry. Working with different Pharmaceutical and CRO companies like Amgen, Allergan, Pfizer and Chiltern Kalman collected experience on several fields of clinical research operation as CRA and project manager. Starting March 2014, as a joint partner, Kalman became the Chief Operating Officer of Research Professionals Ltd., a Hungarian CRO with main focus on Central European Region. In this position his is responsible for conducting of clinical trials and home care services in the region.

Limor Rozner

Limor Rozner is the Business Development Manager and a Project Manager at Pharma Clinical S.A.G (2003) Ltd.

Limor joined Pharma Clinical in 2013 with prior experience in Global pharmaceutical and CRO companies. She has 11 years of extensive experience in clinical trials management, leading multi-national phase II and III trials.In addition to her role as a Business Development Manager and Project Manager, she acts as the country Risk Based Monitoring

Limor holds a Bachelor of Science degree of Biotechnology from Ben-Gurion University of the Negev, Israel.

Mariano Monteagudo

With over 14 years of experience in pharmacology and clinical research, he currently leads the business development and customer relations efforts at Activa-CRO, focused on finding the best solution for project success from regulatory, operational and financial perspectives. Mr. Monteagudo received both his Pharmacist and MBA at Pontificia Universidad Catòlica (UCA) Buenos Aires, ARG, and has held a range of positions of increasing responsibility in the CRO industry, including experience in Quintiles, Merck Sharpe & Dohme Laboratory (MSD), GSK Pharmaceutical, MDS Pharma Services, MDS Pharma Services, INC Research and I3. Joining Activa in 2013, he worked as CTM as well as interacting with clinical operation planning and customer relations with Biotechs, Pharmaceutical company and CROS and his new position since 2015 as Director Business Development Strategy in which he acts as primary contact of client from US, Europe and Asia due in order to develop and stablish a project in the following Latin America countries: Argentina, Chile, Uruguay, Brazil, Peru, Colombia, Panama, Ecuador and Mexico.

Oleksii Mikheiev M.D., Ph.D.

Dr. Oleksii Mikheiev is currently the Chief Executive Officer of verum.de GmbH and, former Verum Regional Managing Director at Cluster Verum Office in CIS Countries (1999-2017). From 2016 till 2018, he headed Clinical Trial Subcommittee of European Business Association (the biggest business community NGO in Ukraine). He joined Verum in 1998 after three years of experience as sub-investigator in phase II-III clinical trials. Totally he has 24 years of experience in clinical trials conduction, and, particularly, 20 years of experience in CRO general management. During last ten years Oleksii Mikheiev has been focused on business development, including creation and development of regional offices network. He manages the CRO with strong and sufficient experience of phase II-IV clinical trials set-up, conduction and follow-up, including several FDA inspections with positive outcomes. He was a member of working groups of Ministry of Health (Ukraine) for drafting the clinical trials legislation in Ukraine. He has experience of collaboration with international organizations (WHO, UNAIDS and UNICEF) as the temporary advisor.

Oleksiy Mykheev holds M.D. degree from the National Medical University in Kiev, Ukraine since 1994, received Ph.D. degree in medicine in 2000 and became associate professor in 2014.

Zoran Acimovic

Owner and CEO 2 GL Outsourcing and CRA Academy- Belgrade, Serbia. Zoran Aćimović holds an IT Master of Science. He has more than 25 years of experience in the IT industry and 15 years of experience in the field of health care and clinical trials. In 2011 Zoran co-founded the CRA Academy, which is the only institution in Serbia which educates professional personal working in clinical research and the pharmaceutical industry.

He has been an organizer of informal training for more than 15 years. As the CEO of 2 GL Outsourcing he can provided various services ranging from clinical trials to regulatory affairs, site and project management, quality assurance, HR management and IT management. He started new services in the ex-Yugoslavia (ex-Yu) region as Mobile Research Nurse and Clinical Site Coordinator. For ten years, he successfully organized conferences for clinical trials in Serbia and the Ex-Yu region.

Nikola Cihoric

Nikola is the founder and the innovative mind behind Wemedoo AG.

With over 15 years of experience in radiation oncology at Switzerland’s largest university hospital, he has garnered a reputation as a visionary in the industry. Nikola’s involvement in various international working groups, such as mCODE, CodeX, HL7/FHIR, CDISC, and DIA Europe, reflects his dedication to advancing clinical data standards, driving innovation, and ensuring the highest quality of clinical data management.

Nikola holds an M.D. in medicine from the University of Belgrade, Serbia, with a specialization in radiation oncology from the University of Berne, Switzerland.